Cytosorbents Corporation (HQE1)
Market Closed
2 Mar, 20:00
XSTU 
€
0. 63
+0.01
+1.61%
€
- Market Cap
- P/E Ratio
- Div Yield
0 Volume
- Eps
€ 0.62
Previous Close Day Range
0.58 0.63
Year Range
0.5 1.07
Want to track HQE1 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
HQE1 earnings report is expected in 27 days (30 Mar 2026)
| Name | Time | Cons. EPS | Eps |
|---|---|---|---|
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
HQE1 Earnings Reports FAQ
What is the earnings per share (EPS) for HQE1?
EPS data for HQE1 is currently not available, as Cytosorbents Corporation has not reported recent earnings.
What is the company's earnings growth rate?
Cytosorbents Corporation has not announced its next earnings release date. You can monitor upcoming announcements in Marketlog's earnings calendar or in the company profile.
When is the next earnings release date?
The next earnings release is expected to be on 2026-03-30, based on the HQE1's typical earnings announcement schedule.
What were the most recent quarterly earnings?
The most recent quarterly earnings for Cytosorbents Corporation are not available at this time.
What is the price-to-earnings (P/E) ratio?
There is no P/E ratio for HQE1 at this time, as Cytosorbents Corporation has no recent EPS data to calculate it.
